LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575740VRecalls & reported problems
Lutonix, Inc. · Lutonix® AV Drug Coated Balloon PTA Catheter 7x40x75 · Class 3
All models of LUTONIX 035 Drug Coated Balloon PTA Catheter (19)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00801741135422), received between Dec 7, 2021 and Sep 10, 2024 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Difficult to Insert” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Difficult to Insert1
- Difficult to Remove1
- Entrapment of Device1
- Material Rupture1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Thrombosis/Thrombus2
- Aneurysm1
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Pseudoaneurysm1
- Restenosis1
- Stenosis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjurySep 10, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT SOMETIME POST AN INDEX PROCEDURE COMPLETION USING A DRUG-COATED BALLOON CATHETER IN THE CEPHALIC VEIN AT OUTFLOW NEAR CANNULATION ZONE VIA THE LEFT UPPER ARM, THE SUBJECT HAD ADVERSE EVENT OF PSEUDOANEURYSM ON PRE-DILATION AND ANEURYSM ON CEPHALIC VEIN. IT WAS FURTHER REPORTED THAT ONE MONTH AND ELEVEN DAYS AFTER INDEX PROCEDURE, THE SUBJECT HAD SERIOUS ADVERSE EVENT DUE TO CEPHALIC VEIN RESTENOSIS AND ACCESS CIRCUIT THROMBOSIS WHICH REQUIRED AN ARTERIOVENOUS ACCESS CIRCUIT REINTERVENTION. FURTHERMORE, ONE MONTH AND NINETEEN DAYS AFTER INDEX PROCEDURE, STANDARD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PROCEDURE WAS PERFORMED TO TREAT CEPHALIC VEIN RESTENOSIS AND ACCESS CIRCUIT THROMBOSIS. TREATMENT REINTERVENTION WAS SUCCESSFUL, NEW ACCESS WAS NOT CREATED, AND THE OUTCOME OF THE SERIOUS ADVERSE EVENT WAS RESOLVED. REPORTEDLY, THERE HAVE BEEN NO DOCUMENTED DEVICE DEFICIENCIES REPORTED FOR THIS SUBJECT TO DATE. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.
Patient problems: Aneurysm; Pseudoaneurysm; Restenosis; Stenosis; Thrombosis/Thrombus
MAUDE report 20179463 ↗InjuryAug 28, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT ONE YEAR AND TWENTY-FIVE DAYS POST INDEX PROCEDURE USING A DRUG COATED BALLOON CATHETER IN THE CEPHALIC VEIN, THE SUBJECT DEVELOPED A SERIOUS ADVERSE EVENT OF OCCLUSION DUE TO THROMBOSIS OF THE CEPHALIC VEIN WHICH REQUIRED ADDITIONAL ARTERIOVENOUS ACCESS CIRCUIT RE-INTERVENTION. IT WAS FURTHER REPORTED THAT ONE YEAR, ONE MONTH, AND ONE DAY AFTER THE INDEX PROCEDURE, THE ACCESS THROMBOSIS IN THE RIGHT UPPER ARM CEPHALIC VEIN HAD A HUNDRED PERCENT INITIAL STENOSIS AND ZERO PERCENT FINAL RESIDUAL STENOSIS. FURTHERMORE, IT WAS ALSO REPORTED THAT THE SUBJECT UNDERWENT THROMBECTOMY AND SURGICAL REVISION OF RIGHT UPPER EXTREMITY THROMBOSED ARTERIOVENOUS FISTULA WITH SIX-MILLIMETER ARTEGRAFT AS AN INTERPOSITION GRAFT TO RESTORE BLOOD FLOW TO THAT ORIGINAL ARTERIOVENOUS FISTULA. THE RE-INTERVENTION WAS NOT SUCCESSFUL, AND SO A NEW ARTERIOVENOUS GRAFT ACCESS WAS SURGICALLY CREATED, AND THE OUTCOME WAS RECOVERED. THE PATIENT'S CURRENT STATUS IS UNKNOWN.
Patient problems: Thrombosis/Thrombus
MAUDE report 17630269 ↗MalfunctionNov 2, 2022Difficult to Insert; Material Rupture; Difficult to Insert; Material Rupture
IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE, THE DRUG-COATED BALLOON ALLEGEDLY DIFFICULT TO PASS THROUGH SHEATH. IT WAS FURTHER REPORTED THAT THE PROXIMAL END OF THE BALLOON ALLEGEDLY PERFORATED. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15713090 ↗MalfunctionDec 7, 2021Entrapment of Device; Difficult to Remove; Entrapment of Device; Difficult to Remove
IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE, THE DEVICE WAS ALLEGEDLY DIFFICULT TO REMOVE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; No Clinical Signs, Symptoms or Conditions
MAUDE report 12947609 ↗
Other Drug-coated peripheral transluminal angioplasty catheter devices
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575760VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter2 deaths60 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575860VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter3 deaths54 reports
- IN.PACT™ AV IAV06008008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter1 recall1 report
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX35751060VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter25 reports
- IN.PACT™ AV IAV08004008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter21 reports
- IN.PACT™ AV IAV08006008PMedtronic, Inc. · Drug-coated peripheral transluminal angioplasty catheter19 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575660VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter1 death19 reports
- LUTONIX ® 035 Drug Coated Balloon PTA Catheter LX3575840VLutonix, Inc. · Drug-coated peripheral transluminal angioplasty catheter17 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page